tiprankstipranks
Trending News
More News >
Profound Medical (TSE:PRN)
TSX:PRN
Canadian Market

Profound Medical (PRN) Financial Statements

Compare
97 Followers

Profound Medical Financial Overview

Profound Medical's market cap is currently C$421.71M. The company's EPS TTM is C$-0.3611427118; its P/E ratio is -6.22; Profound Medical is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.68M$ 7.20M$ 6.68M$ 6.87M$ 7.30M
Gross Profit$ 7.04M$ 4.38M$ 3.02M$ 2.95M$ 3.47M
Operating Income$ -33.06M$ -28.62M$ -29.60M$ -30.29M$ -18.86M
EBITDA$ -32.13M$ -27.00M$ -34.63M$ -28.65M$ -19.50M
Net Income$ -27.82M$ -28.57M$ -28.67M$ -30.70M$ -21.62M
Balance Sheet
Cash & Short-Term Investments$ 54.91M$ 26.21M$ 46.52M$ 67.15M$ 83.91M
Total Assets$ 70.23M$ 43.91M$ 64.42M$ 86.78M$ 104.60M
Total Debt$ 5.12M$ 7.87M$ 8.23M$ 1.38M$ 1.68M
Net Debt$ -49.79M$ -18.35M$ -38.29M$ -65.78M$ -82.24M
Total Liabilities$ 9.81M$ 12.73M$ 12.42M$ 6.16M$ 7.25M
Stockholders' Equity$ 60.42M$ 31.18M$ 52.00M$ 80.62M$ 97.35M
Cash Flow
Free Cash Flow$ -23.45M$ -22.30M$ -25.80M$ -22.95M$ -20.92M
Operating Cash Flow$ -23.45M$ -22.30M$ -25.80M$ -22.36M$ -20.57M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -593.00K$ -350.00K
Financing Cash Flow$ 54.70M$ 1.46M$ 7.03M$ 5.95M$ 87.43M
Currency in USD

Profound Medical Earnings and Revenue History

Profound Medical Debt to Assets

Profound Medical Cash Flow

Profound Medical Forecast EPS vs Actual EPS